MANARA, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.193
EU - Europa 114
AS - Asia 88
OC - Oceania 2
SA - Sud America 1
Totale 1.398
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.193
CN - Cina 84
FI - Finlandia 34
IT - Italia 19
SE - Svezia 19
DE - Germania 16
UA - Ucraina 11
GB - Regno Unito 9
IN - India 3
NL - Olanda 3
RU - Federazione Russa 2
AU - Australia 1
CL - Cile 1
HK - Hong Kong 1
IE - Irlanda 1
NZ - Nuova Zelanda 1
Totale 1.398
Salva come PNG Salva come JPEG
Città #
Fairfield 205
Woodbridge 151
Chandler 144
Ann Arbor 134
Houston 97
Ashburn 75
Seattle 75
Wilmington 53
Cambridge 50
Jacksonville 23
Princeton 21
Beijing 20
Medford 19
San Diego 19
Helsinki 16
Roxbury 16
Nanjing 15
Des Moines 10
Boardman 8
London 7
Cagliari 6
Hebei 6
Jinan 6
Carlisle 5
Kharkiv 5
Hefei 4
Jiaxing 4
Nanchang 4
Padova 4
Shenyang 4
Tianjin 4
Changsha 2
Guangzhou 2
Kunming 2
Lanzhou 2
Norwalk 2
Palermo 2
Amsterdam 1
Auckland 1
Chicago 1
Costa Mesa 1
Dearborn 1
Dublin 1
Fuzhou 1
Haikou 1
Hangzhou 1
Las Vegas 1
Leawood 1
New Bedfont 1
Ogden 1
Pune 1
Rockville 1
Shanghai 1
Strathfield 1
Taizhou 1
Wenzhou 1
Totale 1.241
Salva come PNG Salva come JPEG
Nome #
Epigenetic heterogeneity affects the risk of relapse in children with t(8;21)RUNX1-RUNX1T1-rearranged AML. 131
ICER Evokes Dusp1-p38 Pathway Enhancing Chemotherapy Sensitivity in Myeloid Leukemia 113
miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia. 105
ICER expression inhibits leukemia phenotype and controls tumor progression. 101
MicroRNA-34b promoter hypermethylation induces CREB overexpression and contributes to myeloid transformation. 96
MLL-AF6 fusion oncogene sequesters AF6 into the nucleus to trigger RAS activation in myeloid leukemia. 79
Screening of novel genetic aberrations in pediatric acute myeloid leukemia: a report from the AIEOP AML-2002 study group 78
Presence of high-ERG expression is an independent unfavorable prognostic marker in MLL-rearranged childhood myeloid leukemia. 75
Presence of high-ERG expression is an independent unfavorable prognostic marker in MLL-rearranged childhood myeloid leukemia 71
NOVEL Recurrent Genetic Aberrations in Pediatric AML: An AIEOP AML-2002 Study Group 70
Mir-34b promoter methylation plays a role in myeloid transformation by controlling CREB expression. 64
The cAMP Response Element Binding Protein (CREB) Overexpression Induces Myeloid Transformation in Zebrafish 63
BAG1 Overexpression Restrains the Anti-Apoptotic BCL2, MCL1 and HSP70 Proteins in Acute Myeloid Leukemia 61
CBFA2T3-GLIS2 fusion transcript is a novel common feature in pediatric, cytogenetically normal AML, not restricted to FAB M7 subtype 53
Whole transcriptome sequencing of a paediatric case of de novo acute myeloid leukaemia with del(5q) reveals RUNX1-USP42 and PRDM16-SKI fusion transcripts. 51
Core-binding factor acute myeloid leukemia in pediatric patients enrolled in the AIEOP AML 2002/01 trial: screening and prognostic impact of c-KIT mutations. 44
DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new lanscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia 43
Understanding the mechanism of CREB overexpression in pediatric acute myeloid leukemia 42
CREB e ICER: Nuovi regolatori dell'espressione genica dipendente dall'AMP ciclico nella leucemia acuta pediatrica. 34
The inducible cyclic adenosine 3’,5’-monophosphate early repressor (ICER) ehances chemotherapy sensitivity to myeloid leukemia cells. 31
Totale 1.405
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.118
article - articoli 4.455
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.573
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201987 0 0 0 0 0 0 0 0 0 18 40 29
2019/2020326 41 7 3 14 35 24 30 49 37 45 31 10
2020/2021148 12 12 5 24 3 16 3 18 19 9 17 10
2021/2022245 3 29 26 21 7 7 28 32 10 4 17 61
2022/2023255 36 36 7 36 52 30 0 17 23 1 10 7
2023/202473 6 14 12 8 3 7 12 8 3 0 0 0
Totale 1.405